×
Entrez Id: 57379
Gene Symbol: AICDA
AICDA
0.060
AlteredExpression
disease
BEFREE
AID and TET2 co-operation modulates FANCA expression by active demethylation in diffuse large B cell lymphoma .30357811 2019
×
Entrez Id: 57379
Gene Symbol: AICDA
AICDA
0.060
AlteredExpression
disease
BEFREE
Prognostic impact of activation-induced cytidine deaminase expression for patients with diffuse large B-cell lymphoma .
29251015 2018
×
Entrez Id: 9049
Gene Symbol: AIP
AIP
0.010
AlteredExpression
disease
BEFREE
Our findings describe AIP as a positive regulator of BCL6 expression with implications for the pathobiology of diffuse large B cell lymphoma .
31042473 2019
×
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.070
Biomarker
disease
BEFREE
Frequent copy number variations of PI3K/AKT pathway and aberrant protein expressions of PI3K subunits are associated with inferior survival in diffuse large B cell lymphoma .
24418330 2014
×
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.070
Biomarker
disease
BEFREE
The phosphodiesterase PDE4B limits cAMP-associated PI3K/AKT -dependent apoptosis in diffuse large B-cell lymphoma .
15331441 2005
×
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.070
Biomarker
disease
BEFREE
SPIB is a novel prognostic factor in diffuse large B-cell lymphoma that mediates apoptosis via the PI3K-AKT pathway.
27348272 2016
×
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.070
Biomarker
disease
BEFREE
PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma .
23840064 2013
×
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.070
Biomarker
disease
BEFREE
AKT Hyperactivation and the Potential of AKT -Targeted Therapy in Diffuse Large B-Cell Lymphoma .28627414 2017
×
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.070
Biomarker
disease
BEFREE
MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma .
25909227 2015
×
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.070
Biomarker
disease
BEFREE
Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma .
22609116 2012
×
Entrez Id: 213
Gene Symbol: ALB
ALB
0.040
Biomarker
disease
BEFREE
Prognostic impact of pretreatment albumin to globulin ratio in patients with diffuse large B-cell lymphoma treated with R-CHOP.
30048838 2018
×
Entrez Id: 213
Gene Symbol: ALB
ALB
0.040
Biomarker
disease
BEFREE
The pretreatment albumin to globulin ratio as a significant predictor in patients with diffuse large B cell lymphoma .
30006285 2018
×
Entrez Id: 213
Gene Symbol: ALB
ALB
0.040
Biomarker
disease
BEFREE
Validation and Refinement of the Age, Comorbidities, and Albumin Index in Elderly Patients with Diffuse Large B-Cell Lymphoma : An Effective Tool for Comprehensive Geriatric Assessment.
29317552 2018
×
Entrez Id: 213
Gene Symbol: ALB
ALB
0.040
AlteredExpression
disease
BEFREE
Utility of a simple prognostic stratification based on platelet counts and serum albumin levels in elderly patients with diffuse large B cell lymphoma .
27641425 2017
×
Entrez Id: 216
Gene Symbol: ALDH1A1
ALDH1A1
0.010
Biomarker
disease
BEFREE
ALDH1A1 mediates resistance of diffuse large B cell lymphoma to the CHOP regimen.25344211 2014
×
Entrez Id: 238
Gene Symbol: ALK
ALK
0.100
GeneticVariation
disease
BEFREE
EML4-ALK transcripts were detected in 3/51 (5.9%) of reactive lymphoid tissues and 12/58 (20.7%) of lymphomas of different categories, including follicular lymphoma, diffuse large B-cell lymphoma and Hodgkin's disease.
19734424 2009
×
Entrez Id: 238
Gene Symbol: ALK
ALK
0.100
GeneticVariation
disease
BEFREE
Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK LBCL) is a rare, aggressive subtype of diffuse large B-cell lymphoma with characteristic ALK rearrangements.
27740969 2017
×
Entrez Id: 238
Gene Symbol: ALK
ALK
0.100
Biomarker
disease
BEFREE
ALK -positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases.12763927 2003
×
Entrez Id: 238
Gene Symbol: ALK
ALK
0.100
GeneticVariation
disease
BEFREE
Since the first discovery of anaplastic lymphoma kinase (ALK ) in anaplastic large cell lymphoma (ALCL) by Morris et al in 1994, the number of ALK-positive neoplasms, either in the form of translocation or gain-of-function mutations, have been dramatically expanded from ALCL of T- and NK-cell origin, to diffuse large B-cell lymphoma , inflammatory myofibroblastic tumor (IMT), neuroblastoma, non-small cell lung carcinoma (NSCLC), undifferentiated anaplastic thyroid carcinoma, and rare type of sarcomas.
22808292 2012
×
Entrez Id: 238
Gene Symbol: ALK
ALK
0.100
Biomarker
disease
BEFREE
ALK -positive diffuse large B-cell lymphoma of the stomach associated with a clathrin-ALK rearrangement.15492998 2004
×
Entrez Id: 238
Gene Symbol: ALK
ALK
0.100
Biomarker
disease
BEFREE
Anaplastic lymphoma kinase -positive diffuse large B-cell lymphoma with a complex karyotype and cryptic 3' ALK gene insertion to chromosome 4 q22-24.17509395 2007
×
Entrez Id: 238
Gene Symbol: ALK
ALK
0.100
Biomarker
disease
BEFREE
Acute spontaneous tumor lysis syndrome as the initial presentation of ALK -positive diffuse large B-cell lymphoma .
24717232 2014
×
Entrez Id: 238
Gene Symbol: ALK
ALK
0.100
Biomarker
disease
BEFREE
ALK -positive diffuse large B-cell lymphoma : report of four cases and review of the literature.17277765 2007
×
Entrez Id: 238
Gene Symbol: ALK
ALK
0.100
Biomarker
disease
BEFREE
Anaplastic lymphoma kinase -positive diffuse large B-cell lymphoma : a rare clinicopathologic entity with poor prognosis.19636007 2009
×
Entrez Id: 238
Gene Symbol: ALK
ALK
0.100
Biomarker
disease
BEFREE
Anaplastic lymphoma kinase protein positive diffuse large B cell lymphoma ; A developing world experience.28551388 2017